CR10206A - Acidos4-fenil-tiazol-5-carboxilicos amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1 - Google Patents

Acidos4-fenil-tiazol-5-carboxilicos amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1

Info

Publication number
CR10206A
CR10206A CR10206A CR10206A CR10206A CR 10206 A CR10206 A CR 10206A CR 10206 A CR10206 A CR 10206A CR 10206 A CR10206 A CR 10206A CR 10206 A CR10206 A CR 10206A
Authority
CR
Costa Rica
Prior art keywords
tiazol
phenyl
acids
carboxylics
plk1
Prior art date
Application number
CR10206A
Other languages
English (en)
Inventor
Frederick Boylan John
Cai Jianping
Fotouhi Nader
Gillespie Paul
Alan Goodnow Robert Jr
Le Kang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CR10206A publication Critical patent/CR10206A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

La invención se refiere a compuestos de la fórmula (1) y a sales farmacéuticamente aceptables de los mismos, a métodos para su obtención y a métodos para la utilización de los mismos.
CR10206A 2006-02-27 2008-08-14 Acidos4-fenil-tiazol-5-carboxilicos amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1 CR10206A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77696406P 2006-02-27 2006-02-27

Publications (1)

Publication Number Publication Date
CR10206A true CR10206A (es) 2008-09-22

Family

ID=38051896

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10206A CR10206A (es) 2006-02-27 2008-08-14 Acidos4-fenil-tiazol-5-carboxilicos amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1

Country Status (19)

Country Link
US (1) US7504513B2 (es)
EP (1) EP1991543A1 (es)
JP (1) JP2009528284A (es)
KR (1) KR101060539B1 (es)
CN (1) CN101415704A (es)
AR (1) AR059621A1 (es)
AU (1) AU2007217575A1 (es)
BR (1) BRPI0710473A2 (es)
CA (1) CA2642921A1 (es)
CR (1) CR10206A (es)
EC (1) ECSP088700A (es)
IL (1) IL193481A0 (es)
MA (1) MA30260B1 (es)
MX (1) MX2008010884A (es)
NO (1) NO20083708L (es)
RU (1) RU2008138163A (es)
TW (1) TW200745097A (es)
WO (1) WO2007096315A1 (es)
ZA (1) ZA200807074B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008149784A1 (ja) * 2007-06-08 2008-12-11 Nec Corporation 半導体集積回路及びフィルタ制御方法
US9029411B2 (en) 2008-01-25 2015-05-12 Millennium Pharmaceuticals, Inc. Thiophenes and uses thereof
AU2008354754B2 (en) * 2008-04-17 2014-09-11 The Johns Hopkins University On01910. Na enhances chemotherapeutic agent activity in drug-resistant tumors
BRPI0918427A2 (pt) * 2008-09-10 2018-05-22 Datalase Ltd meio de armazenamento de dados
WO2010077295A1 (en) * 2008-12-09 2010-07-08 King Faisal Specialist Hospital & Research Centre Substituted tricyclic heterocycles and uses to treat tumors and proliferative disorders
CA2745596A1 (en) * 2008-12-18 2010-10-28 F. Hoffmann-La Roche Ag Thiazolyl-benzimidazoles
CN102395585A (zh) 2009-01-30 2012-03-28 米伦纽姆医药公司 杂芳基化合物和其作为pi3k抑制剂的用途
US9090601B2 (en) * 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
EA201390214A1 (ru) 2010-08-11 2013-07-30 Милленниум Фармасьютикалз, Инк. Гетероарилы и их применение
JP2013533318A (ja) 2010-08-11 2013-08-22 ミレニアム ファーマシューティカルズ, インコーポレイテッド ヘテロアリールおよびその使用
US9062038B2 (en) 2010-08-11 2015-06-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
KR20140091462A (ko) 2010-10-13 2014-07-21 밀레니엄 파머슈티컬스 인코퍼레이티드 헤테로아릴 및 그의 용도

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322429A (en) * 1980-09-16 1982-03-30 Eli Lilly And Company Isoxazolylbenzamides as insecticides
US4818270A (en) * 1986-08-28 1989-04-04 Monsanto Company 2-(Heteroamino)-4,5-substituted-oxazole/thiazole compounds as herbicide antidotes, compositions and use
US6194447B1 (en) * 1998-07-02 2001-02-27 Neurosearch A/S Bis (benzimidazole) derivatives serving as potassium blocking agents
JP4555547B2 (ja) 2000-08-10 2010-10-06 ファイザー イタリア ソシエタ ア レスポンサビリタ リミタータ キナーゼ阻害剤としての二環式ピラゾール、それらを製造するための方法およびそれらを含む医薬組成物
GB0102687D0 (en) 2001-02-02 2001-03-21 Pharmacia & Upjohn Spa Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
US20050107316A1 (en) 2002-02-22 2005-05-19 Klaus Strebhardt Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent
AU2003211385A1 (en) * 2002-02-28 2003-09-09 Takeda Chemical Industries, Ltd. Azole compounds
ES2373945T3 (es) 2002-02-28 2012-02-10 Temple University - Of The Commonwealth System Of Higher Education Bencilsulfonas de (e)-2,6-dialcoxiestirilo amino sustituido sustituidas en 4 para tratar trastornos proliferativos.
JP2003321460A (ja) * 2002-02-28 2003-11-11 Takeda Chem Ind Ltd アゾール化合物
JP2005538048A (ja) 2002-05-03 2005-12-15 シエーリング アクチエンゲゼルシャフト チアゾリジノン類、それらの生成及び医薬剤としての使用
US6906186B1 (en) 2002-07-30 2005-06-14 Isis Pharmaceuticals, Inc. Antisense modulation of polo-like kinase expression
US20060074119A1 (en) * 2002-08-08 2006-04-06 Andrews Clarence W Iii Thiophene compounds
WO2004043936A1 (ja) 2002-11-14 2004-05-27 Kyowa Hakko Kogyo Co., Ltd. Plk阻害剤
AU2003290883A1 (en) 2002-11-14 2004-06-15 Lewis C. Cantley Products and processes for modulating peptide-peptide binding domain interactions
WO2004054186A1 (ja) 2002-12-12 2004-06-24 Fujitsu Limited データ中継装置、連想メモリデバイス、および連想メモリデバイス利用情報検索方法
GB0302220D0 (en) 2003-01-30 2003-03-05 Cyclacel Ltd Use
JP4634367B2 (ja) 2003-02-20 2011-02-16 スミスクライン ビーチャム コーポレーション ピリミジン化合物
EP1608656B1 (en) 2003-04-01 2009-06-03 SmithKline Beecham Corporation Imidazotriazine compounds for the treatment of cancer diseases
ES2315663T3 (es) 2003-06-24 2009-04-01 Pfizer Products Incorporated Procedimiento para la preparacion de derivados de 1-((benzoimidazol-1-il)quinolin-8-il)piperidin-4-ilamina.
WO2005019193A2 (en) 2003-08-20 2005-03-03 Smithkline Beecham Corporation Phenylurea derivatives useful in the treatment of conditions mediated by polo-like kinases (plk)
CA2542880A1 (en) 2003-10-21 2005-05-12 Cyclacel Limited Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy
DE10351744A1 (de) 2003-10-31 2005-06-16 Schering Ag Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel
WO2005075470A1 (en) 2004-01-28 2005-08-18 Smithkline Beecham Corporation Thiazole compounds

Also Published As

Publication number Publication date
KR20080090550A (ko) 2008-10-08
JP2009528284A (ja) 2009-08-06
US7504513B2 (en) 2009-03-17
US20070203210A1 (en) 2007-08-30
TW200745097A (en) 2007-12-16
CA2642921A1 (en) 2007-08-30
MA30260B1 (fr) 2009-03-02
KR101060539B1 (ko) 2011-08-30
ECSP088700A (es) 2008-09-29
NO20083708L (no) 2008-09-23
BRPI0710473A2 (pt) 2011-08-16
AR059621A1 (es) 2008-04-16
CN101415704A (zh) 2009-04-22
RU2008138163A (ru) 2010-04-10
AU2007217575A1 (en) 2007-08-30
IL193481A0 (en) 2009-05-04
WO2007096315A1 (en) 2007-08-30
ZA200807074B (en) 2009-10-28
MX2008010884A (es) 2008-09-03
EP1991543A1 (en) 2008-11-19

Similar Documents

Publication Publication Date Title
CR10206A (es) Acidos4-fenil-tiazol-5-carboxilicos amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
DOP2010000047A (es) Compuestos de pirazol y su uso como inhibidores de raf
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
SV2010003598A (es) Derivados de tiazol usados como inhibidores de pi 3-cinasa
UY31468A1 (es) Derivados bis-(sulfonilamino) en terapia 065
CR11518A (es) Compuestos de carbamoilo como inhibidores de dgat1 190
CU20110235A7 (es) Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17
UY31870A (es) Receptor metabotrópico de glutamato potenciadores 286
ECSP10010178A (es) Derivados bis-(sulfonilamino) en terapia 066
AR062745A1 (es) 2-[4-(7-etil-5h-pirrolo[2,3-b]pirazin-6-il)-fenil]-propan-2-ol como inhibidor de quinasa
CR10968A (es) Nuevos derivados de 3-amino-pirrolo[3,4-c]pirazol -5(1h, 4h, 6h) carbaldehido
ECSP10010272A (es) Derivados bis-(sulfonilamino) para uso en terapia
ECSP099721A (es) Inhibidores de cinasa p70 s6
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
ECSP055853A (es) Nuevos derivados de fluoroglicosidos heterociclicos, productos farmaceuticos que contienen dichos compuestos, y el uso de los mismos
GT200600117A (es) Nuevos compuestos farmaceuticos
DOP2006000243A (es) Derivados de pirazina
NI201000157A (es) Inhibidores desacetilasas b a base de hidroxamato.
DOP2011000134A (es) Lactamas como inhibidores de beta secretasa
ECSP088229A (es) Derivados de pirazolona como inhibidores de 11-beta hsd1
NI200900155A (es) COMPUESTOS DE 2-AMINO PIRIMIDINA. Caso: PC 33441A
EA200801893A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления
RS52108B (en) 3-SUBSTITUTED [1,2,3] -BENZOTRIAZINONE UNIT TO INCREASE GLUTAMATERGIC SYNAPTIC ANSWERS
CO6321280A2 (es) Nueva clase espiro piperidinas para el tratamiento de enfermedades neurodegenerativas
UY29804A1 (es) Quinolinas de alquilnitrilo

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)